A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/66 (2006.01) A61K 38/17 (2006.01) A61P 11/00 (2006.01)
Patent
CA 2637644
Patients suffering from acute respiratory distress syndrome or acute lung injury are treated by administering to the patients a therapeutically effective dosage of a surfactant that includes SP-B and phospholipid at a concentration of SP-B relative to concentration of phospholipid that is sufficient to produce detectable SP-B dependent activity.
La présente invention concerne des patients souffrant d~un syndrome de détresse respiratoire aigu ou d~une lésion pulmonaire aiguë qui sont traités par l'administration d~une dose thérapeutiquement efficace d'un tensioactif comprenant un SP-B et un phospholipide selon un rapport de concentration de SP-B sur le phospholipide suffisant pour produire une activité dépendant de SP-B détectable.
Egan Edmund A.
Holm Bruce
Perry + Currier
Pneuma Partners Llc.
Pneuma Pharmaceuticals Inc.
LandOfFree
Treatment of acute respiratory distress syndrome does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of acute respiratory distress syndrome, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of acute respiratory distress syndrome will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1692543